TipRanks
Arcadia Biosciences (DE:17D)
FRANKFURT:17D
Germany Market

Arcadia Biosciences (17D) Income Statement

0 Followers

Arcadia Biosciences Income Statement

Last quarter (Q2 2026), Arcadia Biosciences's total revenue was $1.44M, a decrease of -0.82% from the same quarter last year. In Q2, Arcadia Biosciences's net income was $-6.27M. See Arcadia Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 4.86M$ 5.04M$ 4.45M$ 7.42M$ 6.78M
Gross Profit
$ 1.76M$ 2.08M$ 2.28M$ 1.32M$ -1.93M
Operating Expenses
$ 11.76M$ 5.73M$ 8.38M$ 15.32M$ 33.60M
Depreciation and Amortization
$ 32.00K$ 113.00K$ 287.00K$ 479.00K$ 1.04M
EBITDA
$ -2.30M$ -7.50M$ -5.73M$ -14.75M$ -27.71M
Operating Income
$ -9.99M$ -3.65M$ -6.10M$ -14.01M$ -35.53M
Other Income/Expenses
$ 7.66M$ -661.00K$ 781.00K$ 3.19M$ 19.39M
Pretax Income
$ -2.33M$ -4.31M$ -5.32M$ -10.81M$ -16.13M
Net Income
$ -2.34M$ -7.04M$ -13.98M$ -15.38M$ -14.66M
Per Share Metrics
Basic EPS
$ -1.71$ -5.16$ -11.30$ -26.05$ -30.33
Diluted EPS
$ -1.71$ -5.16$ -11.30$ -26.05$ -30.33
Weighted Average Shares Outstanding
1.37M 1.36M 1.24M 599.39K 532.01K
Weighted Average Shares Outstanding (Diluted)
1.37M 1.36M 1.24M 599.39K 532.01K
Currency in USD

Arcadia Biosciences Earnings and Revenue History